A Dose Escalation and Expansion Study of MVC-101 in Patients With Advanced Cancer
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK),
pharmacodynamics and preliminary antitumor activity of MVC-101